Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Identix (IDNX) -- Ignore unavailable to you. Want to Upgrade?

To: David who wrote (9852)	8/9/1998 1:53:00 PM
From: jean	Respond to of 26039

Competitor for Time and Attendance? Jean web.lexis-nexis.com

To: David who wrote (9852)	8/9/1998 5:04:00 PM
From: jean	Read Replies (1) \| Respond to of 26039

Dave in DC...Dragged the following Yahoo post by sspenard over here FYI. Thought you should see the well-deserved compliment, especially since he usually expresses contempt for SI posters. Jean >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> David (a smart guy)on SI says Identicator has annual revenues of about $7 million.I believe Identicator is only involved with commercial Bio-Id markets.This is the key market. Lets break IDX down.Annual revs of $79 million.$44 million of this rev comes from Anadac which has nothing to do with Bio-Id.This leaves $35 million for product sales.The vast majority of these sales is for the TP600 which is for AFIS not commercial Bio-Id market.I'll assume 90% of product sales are for TP600.This is about $31 million.This leaves IDX with commercial Bio-Id sales of about $4 million annually. If I am close in my assumption,Identicator may have more sales in the Bio-Id market(if David's $7 mil figure is correct for Identicator) than IDX. So I have to disagree with David saying Identicator is an IPO to avoid and there is not much there.If Identicator has any success with their products with Compaq and Mastercard this could hurt IDX because I do not think they have a product to compete with at this price point.Maybe the F3?Maybe not. The Bio-Id market is up for grabs and IDX has not capitalized on it yet.This Oracle product they have may not be at the right price point to get it widely deployed.Maybe it is buggy,who knows since we get little info from IDX about this product that has no sales.I don't think you can blame the marketplace for no sales after about 3 years.Pilots don't last three years...maybe a year, 18 months tops. I have a good chunk of change on IDX hoping it can be a major player in the Bio-Id market..so far it really hasn't made a dent in this market.But in the meantime,I think Identicator can be a player in this market and would buy their shares if they go public.Buying Identicator can't be any worse than my losses with IDX so far.And maybe Identicator will have a better relationship with their shareholders and the Street than IDX has. Any Identicator guys out there to give us some info?Or IDX guys for that matter.